Simplex Trading’s Aratana Therapeutics, Inc. PETX Stock Holding History

Simplex Trading’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-56	Closed	-$28K	–	8324
2019 Q2	$28K	Sell	56 -46	-45%	-$207	﹤0.01%	5347
2019 Q1	$36K	Buy	+102	New	+$442	﹤0.01%	5272
2018 Q2	–	Sell	-56	Closed	-$15K	–	8211
2018 Q1	$15K	Buy	56 +5	+10%	+$22	﹤0.01%	3671
2017 Q4	$4K	Sell	51 -108	-68%	-$661	﹤0.01%	4810
2017 Q3	$16K	Buy	159 +82	+106%	+$519	﹤0.01%	3398
2017 Q2	$3K	Sell	77 -10	-11%	-$61	﹤0.01%	5117
2017 Q1	$10K	Buy	+87	New	+$587	﹤0.01%	4013
2016 Q3	–	Sell	-62	Closed	-$4K	–	6834
2016 Q2	$4K	Buy	62 +12	+24%	+$77	﹤0.01%	4535
2016 Q1	$12K	Buy	50 +42	+525%	+$158	﹤0.01%	3351
2015 Q4	$4K	Sell	8 -3	-27%	-$20	﹤0.01%	4114
2015 Q3	$4K	Buy	+11	New	+$186	﹤0.01%	4254

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Simplex Trading's PETX Position: Q3 2019 in Review

Simplex Trading sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 10,159 shares — an estimated $52K sold.

Simplex Trading first reported a position in PETX in Q1 2015 and held it in 11 quarters. The position peaked at $84K in Q1 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Simplex Trading reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Simplex Trading sold 10,159 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $52K.
Simplex Trading first reported a position in Aratana Therapeutics, Inc. in Q1 2015 and held it in 11 quarters.
Simplex Trading's Aratana Therapeutics, Inc. position peaked at $84K in Q1 2019.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Simplex Trading's 13F filing for Q3 2019, filed 15 Oct 2019.